# A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants.

> **NCT03530917** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 70 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** RO7020531
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03530917
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-15
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-05-15
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2020-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03530917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03530917, "A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants.". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03530917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*